Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

TADAWUL:4015 Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,362	10,654	8,050	-	-	-
Market Cap Growth	22.84%	32.35%	-	-	-	-
Enterprise Value	12,226	10,534	7,954	-	-	-
Last Close Price	176.60	150.87	111.66	-	-	-
PE Ratio	30.11	29.88	27.53	-	-	-
Forward PE	26.59	25.61	25.41	-	-	-
PS Ratio	8.89	8.08	7.31	-	-	-
PB Ratio	7.99	7.15	5.73	-	-	-
P/TBV Ratio	8.07	7.20	5.79	-	-	-
P/FCF Ratio	47.40	51.60	32.10	-	-	-
P/OCF Ratio	40.65	40.46	27.20	-	-	-
PEG Ratio	1.90	1.60	1.01	-	-	-
EV/Sales Ratio	8.79	7.99	7.23	-	-	-
EV/EBITDA Ratio	25.52	24.82	23.28	-	-	-
EV/EBIT Ratio	27.82	27.16	25.19	-	-	-
EV/FCF Ratio	46.88	51.02	31.72	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.08
Debt / EBITDA Ratio	0.01	0.00	0.01	0.01	0.01	0.34
Debt / FCF Ratio	0.01	0.01	0.01	0.02	0.02	0.86
Asset Turnover	0.76	0.77	0.72	0.65	0.50	0.58
Inventory Turnover	2.26	1.98	2.18	2.44	1.97	2.99
Quick Ratio	3.14	3.65	3.58	4.16	3.90	2.90
Current Ratio	4.28	5.10	5.04	5.42	5.06	3.54
Return on Equity (ROE)	27.30%	24.63%	22.32%	14.00%	14.16%	18.40%
Return on Assets (ROA)	14.28%	14.15%	12.89%	10.67%	7.93%	10.79%
Return on Capital (ROIC)	17.37%	16.72%	15.04%	12.36%	9.25%	12.59%
Return on Capital Employed (ROCE)	25.60%	24.70%	21.40%	18.90%	14.40%	19.10%
Earnings Yield	3.32%	3.35%	3.63%	-	-	-
FCF Yield	2.11%	1.94%	3.12%	-	-	-
Dividend Yield	1.73%	2.03%	2.24%	-	-	-
Payout Ratio	77.74%	60.87%	23.94%	86.85%	66.40%	43.83%
Buyback Yield / Dilution	-	-	-	-600.00%	-	-
Total Shareholder Return	1.73%	2.03%	2.24%	-600.00%	-	-

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.